Meral Beksac

4PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 05, 2022
Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

Andrew Spencer, Olga Samoilova, Wee-Joo Chng

|Feb 15, 2022
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.

Dawn Swan, Patrick J Hayden, Dirk-Jan Eikema

|Mar 16, 2021
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

Laura Rosiñol, Meral Beksac, Elena Zamagni

|Sep 05, 2020
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.

Meletios A Dimopoulos, Sagar Lonial, Darrell White

Pageof 1

Frequent Collaborators

2 joint publications

Meletios-Athanasios Dimopoulos

2 joint publications

Maria-Victoria Mateos

2 joint publications

Hermann Einsele

1 joint publications

Sebastian Grosicki